Psoriatic Arthritis Treatment in New Jersey
Fellowship-Trained Rheumatologists Serving Patients at Multiple Locations Throughout South & Central Jersey & Philadelphia
For more than 50 years, Arthritis, Rheumatic & Bone Disease Associates has helped patients across our broad service area manage a variety of rheumatic conditions, including psoriatic arthritis. Founded in 1974, our independent practice diagnoses, treats, and medically manages chronic diseases, all under the care of fellowship-trained, board-certified or board-eligible rheumatologists.
We bring the full treatment stack for psoriatic arthritis under one roof: in-office diagnostic ultrasounds interpreted by a rheumatology-trained physician and on-site biologic infusion centers at seven locations that can complete as many as 29,000 infusions for over 8,000 patients in one year. Our clinical trial involvement and nationally recognized team mean you’re receiving care informed by the latest advances in rheumatology.
If you’re experiencing joint pain, skin symptoms, or other signs of psoriatic arthritis, call Arthritis, Rheumatic & Bone Disease Associates today at (856) 424-5005 to schedule a consultation with a fellowship-trained rheumatologist!
Psoriatic Arthritis Treatment Options at Arthritis, Rheumatic & Bone Disease Associates
Psoriatic arthritis is a chronic condition that requires long-term monitoring and ongoing treatment adjustment. Our rheumatologists build each treatment plan around your specific diagnosis, disease severity, lifestyle, and medical history. Treatment typically progresses from less intensive to more targeted therapies as needed.
NSAIDs and Corticosteroids
Nonsteroidal anti-inflammatory drugs (NSAIDs) are commonly used to manage pain and reduce inflammation, particularly in milder cases. Corticosteroids such as prednisone can be taken orally or administered by injection to control inflammation and manage flare-ups, though they don’t prevent joint damage over time.
Conventional DMARDs
Conventional disease-modifying antirheumatic drugs (cDMARDs) such as methotrexate reduce inflammation over time. They may take several weeks to reach full effectiveness and are typically used when NSAIDs alone are insufficient.
Biologic Therapies and In-Office Infusions at Arthritis, Rheumatic & Bone Disease Associates
Biologic DMARDs (bDMARDs) target specific pathways of the immune system that drive inflammation and represent a major advance in psoriatic arthritis treatment. TNF inhibitors include adalimumab (HUMIRA), etanercept (ENBREL), golimumab (SIMPONI ARIA), and infliximab (REMICADE). IL-17 and IL-23 inhibitors such as secukinumab (COSENTYX) and ustekinumab (STELARA) address inflammation at the cellular level.
Many biologic therapies are delivered by infusion. Through our IDYLLIC Infusion Treatment Centers, located within all of our offices, patients can access these advanced treatments without a hospital stay.
JAK Inhibitors and PDE4 Inhibitors
For patients who prefer or require oral options, JAK inhibitors, including tofacitinib (XELJANZ) and upadacitinib (RINVOQ), can reduce inflammation without an infusion. OTEZLA (apremilast), a PDE4 inhibitor, is also an alternative for patients with milder forms of psoriatic arthritis.
Call Arthritis, Rheumatic & Bone Disease Associates at (856) 424-5005 to discuss the psoriatic arthritis treatment options available to you!
OUR PRACTICE by the Numbers
Over fifty years of independent rheumatology care, measured in facts.
-
50 +Years in Practice
Founded in 1974. Still independent. Still focused exclusively on rheumatology.
-
29,000 +INFUSIONS IN A SINGLE YEAR
Completed across seven IDYLLIC Infusion Treatment Centers, all inside our offices.
-
18Providers
Every one fellowship-trained in rheumatology and board-certified or board-eligible.
-
7New Jersey Offices
Serving South and Central Jersey and the Philadelphia region from Voorhees to Brick.